Results 41 to 50 of about 6,002,276 (336)

Efficacy and safety of allergen-specific immunotherapy for allergic asthma: a meta-analysis comparing sublingual and subcutaneous routes across allergen types and age groups

open access: yesAnnals of Medicine
Purpose This meta-analysis aims to evaluate the efficacy and safety of allergen-specific immunotherapy (AIT) in treating allergic asthma.Methods A comprehensive search across PubMed, Cochrane Library, Embase and Web of Science was conducted.
Weimou Yin   +7 more
doaj   +1 more source

Disease-associated gut microbiome and metabolome changes in patients with chronic obstructive pulmonary disease

open access: yesNature Communications, 2020
Chronic obstructive pulmonary disease (COPD) is the third commonest cause of death globally, and manifests as a progressive inflammatory lung disease with no curative treatment. The lung microbiome contributes to COPD progression, but the function of the
K. Bowerman   +13 more
semanticscholar   +1 more source

Invasive pericardial and pulmonary aspergillosis by uncommon Aspergillus species in anti-interferon-γ autoantibody-associated immunodeficiency: a case report

open access: yesFrontiers in Medicine
This case report describes a 51-year-old female patient who presented with dyspnea and was diagnosed with invasive aspergillosis affecting the pericardium and lungs, secondary to immunodeficiency syndrome caused by anti-interferon-γ autoantibodies ...
Junyuan Tang   +9 more
doaj   +1 more source

The Evaluation of Pulmonary Function Tests in Patients with Polycystic Ovary Syndrome [PDF]

open access: yesJournal of Cardio-Thoracic Medicine, 2013
Introduction: Recently a relation between female sex hormones and severity of asthma symptoms has been proposed. As a common endocrine dysfunction, polycystic ovary syndrome (PCOS) could significantly influence the level of sex hormones in PCOS patients.
Davood Attaran   +5 more
doaj  

Transcriptional down-regulation of suppressor of cytokine signaling (SOCS)-3 in chronic obstructive pulmonary disease [PDF]

open access: yes, 2013
Background: Tobacco is a leading environmental factor in the initiation of respiratory diseases and causes chronic obstructive pulmonary disease (COPD).
Groneberg, David A.   +14 more
core   +1 more source

Impact of fecal microbiota transplantation on lung function and gut microbiome in an ARDS rat model: A multi-omics analysis including 16S rRNA sequencing, metabolomics, and transcriptomics

open access: yesInternational Journal of Immunopathology and Pharmacology
Objective: Acute respiratory distress syndrome (ARDS) is a severe pulmonary condition characterized by inflammation and lung damage, frequently resulting in poor clinical outcomes. Recent studies suggest that the gut-lung axis, mediated by gut microbiota,
Dongwei Zhang   +6 more
doaj   +1 more source

Cardiovascular pathology in patients with newly diagnosed tuberculosis and chronic obstructive pulmonary disease

open access: yesМедицинский совет, 2021
Introduction. Chronic obstructive pulmonary disease and cardiovascular diseases (arterial hypertension, ischemic heart disease, chronic heart failure) are among the comorbid conditions that mutually aggravate each other.
N. V. Bagisheva   +3 more
doaj   +1 more source

Long-acting beta2-agonists for chronic obstructive pulmonary disease. [PDF]

open access: yes, 2013
BACKGROUND: Chronic obstructive pulmonary disease (COPD) is a respiratory disease that causes progressive symptoms of breathlessness, cough and mucus build-up.
Walters, JA   +5 more
core   +1 more source

Global burden of medication non-adherence in chronic obstructive pulmonary disease (COPD) and asthma: a narrative review of the clinical and economic case for smart inhalers

open access: yesJournal of Thoracic Disease, 2021
Medication non-adherence to asthma and chronic obstructive pulmonary disease therapy poses a significant burden for patients and societies. Non-adherence encompasses poor initiation, implementation (including poor inhalation technique) and non ...
Evalyne M Jansen   +5 more
semanticscholar   +1 more source

Safety and Effectiveness of a High‐Dose, Tailored Tissue Plasminogen Activator Therapy Protocol: A Joint Pediatric Hematology and Cardiac ICU Quality Improvement Initiative Analysis

open access: yesPediatric Blood &Cancer, EarlyView.
ABSTRACT Background Pediatric thromboembolism is increasingly encountered in critical care. Systemic thrombolysis with tissue plasminogen activator (tPA) facilitates vessel or valve patency, yet pediatric‐specific protocols remain undefined, and safety concerns persist. Objective To evaluate the efficacy and safety of a tailored, prolonged systemic tPA
Eran Shostak   +5 more
wiley   +1 more source

Home - About - Disclaimer - Privacy